ECHO Connection

  • EDUCATION
    • EDUCATION BLOG
  • COLLABORATION
    • DOCTOR SIGNUP
  • HOPE
    • ECHO FAMILIES
    • APPLICATION
  • ABOUT
    • ORGANIZATION UPDATES
    • CONTACT
DONATEEuropean Donation

Study Finds HIV Patients Can Safely Use Cannabinoids Without Risk to Immune System

by ECHO / Monday, 10 July 2017 / Published in Education, Overview of Cannabinoids, Scientific Cannabinoid Research

A recent study has found that cannabinoids do not adversely affect the immune system of patients diagnosed with both human immunodeficiency virus (HIV) and hepatitis C virus (HCV). Investigator Fabienne Marcellin and a team of researchers from the French Institute of Health and Medical Research surveyed 955 HIV and HCV patients to determine whether using cannabinoids to help manage symptoms had any impact on their T-cell count.

T-cells, or CD4 cells, are a type of white blood cells that play a significant role in the body’s immune system. HIV attacks these cells, leaving patients highly susceptible to not being able to fight off health threats like diseases and infections.

Patients diagnosed with HIV commonly incorporate medical cannabinoids into their treatment regimens in an effort to manage what are often debilitating symptoms of the disease. According to the study, cannabinoids have also been shown to help HIV patients reduce the nausea and vomiting, appetite loss, pain, heart disease, and bone tissue breakdown that often accommodates antiretroviral therapy (HAART). Of the 955 patients surveyed, 48 percent reported using cannabinoids within at least four weeks before completing the questionnaire.

The subsequent impact of cannabinoids on the immune system of HIV patients had generally been unstudied. However, a 2003 placebo-controlled clinical trial found cannabinoids had no ill effects on CD4 cell counts in HIV-positive individuals. The new study by Marcellin and his team also found cannabinoids to have no adverse impact on T-cells.

“Findings show no evidence for a negative effect of [cannabinoid] use on circulating CD4 T-cell counts/percentages in HIV-HCV co-infected patients,” Marcellin concluded in the study.

The researchers did note that investigations into the potential impact on CD4 levels in the lungs and on the functional properties of cells are still needed.

Still, the findings are encouraging to medical professionals, who often recommend cannabinoids to those with HIV for symptom management.


You can learn more about cannabinoids, as well as what research has so far discovered about their natural health benefits, by visiting our education page.

We also recommend these related articles:

  • Common Misconceptions About Cannabinoids
  • 4 Questions You Need to Ask About Your Cannabinoid Product

Keep up with the latest updates at ECHO by following us on Facebook, Twitter, Instagram, and Pinterest.

Tagged under: Cannabinoids, HIV, research

What you can read next

CBD For Horses
What are Cannabinoids?
Pain: Cannabinoids and CBD Research Overview

Recent Posts

  • ECHO Announces Changes to Leadership

    We are making a few changes at ECHO Connection ...
  • Five States That Will Definitely Have Cannabis Legalization on the Ballot in November

    In any other year, cannabis legalization on the...
  • The Top Six CBD Podcasts to Listen to This Fall

    It’s no secret that the world is on a can...
  • Study Shows That Many CBD Beverages Contain Less or More Cannabidiol Than Advertised

    With CBD beverages increasing in popularity, it...
  • Beyond Ancestry—Cannabis DNA Tests Could Help You Find Your Ideal Strain

    By now, we’re all familiar with DNA test kits. ...

Receive the latest ECHO news by joining our newsletter.

  • Home
  • Education
  • Collaboration
  • Hope
  • ECHO Families
  • About
  • Blog
  • Contact

Privacy Policy   |   Terms of Use

Image credits: CMW Media

Notice: ECHO Connection is a 501(c)(3) non-profit organization, U.S. Federal Tax ID 81-4542024.  ECHO is also recognized as a charitable organization, Algemeen nut Beogende Instelling (ANBI) in the Netherlands, RSIN 8256 57 520.

2017 ECHO Connection™ - All Rights Reserved

TOP
ECHO Connection Website

The information contained in this website is for general information and educational purposes only. It does not constitute medical advice. Therefore, any reliance you place on such information is strictly at your own risk. Please check with your medical doctor before starting or changing your CBD routine.

By entering this site you agree to our TERMS OF SERVICE and PRIVACY POLICY.